Pharma & Biotech

The investment case for pharmaceutical giant Novo Nordisk is encountering significant pressure. A combination of revised analyst outlooks, emerging legal...

Shares of clinical-stage biopharmaceutical company Ocugen saw elevated trading activity on Monday, with volume running 72% above the average. This...

A significant disconnect has emerged between Healwell AI Inc.'s operational results and its stock market valuation. Despite posting record-breaking quarterly...

Ocugen's stock closed at $1.38 on Friday, marking a single-day gain of 5.34%. This advance represents the third consecutive trading...

The biotechnology firm Ocugen enters the new trading week with positive momentum. Following a multi-day advance, investors are assessing whether...

A California jury has delivered a significant legal blow to Johnson & Johnson, ordering the healthcare giant to pay $40...

After a period of significant volatility, shares of X4 Pharmaceuticals may be entering a phase of consolidation. The stock closed...

Investors in Neximmune are facing the prospect of an exceptionally turbulent trading session. Market analysis indicates the biotechnology firm's stock...

Shares of Aadi Bioscience have demonstrated stability as the biotechnology firm executes a fundamental strategic overhaul. The company is shifting...

A prominent financial publication's recent endorsement has refocused investor attention on Viking Therapeutics and its potential trajectory through 2026. The...